semaglutide essence Exciting Phase 3 Data from Novo Nordisk for Patients with MASH Semaglutide 1.75mg - 4 injections

After selecting a new dosing day, once weekly dosing should be continued

If only skin can be grasped, give the shot at a 45-degree angle

Most providers recommend continuing at a stable maintenance dose unless you and your clinician decide discontinuation fits your goals

Muscle Loss Concerns With GLP-1 Medications One of the biggest conversations happening around modern weight loss medications right now is lean muscle mass

GLP-1 signaling has been shown to inhibit activation of the NLRP3 inflammasome, a key driver of innate immune-mediated inflammation, and to enhance Treg activity, suggesting a broader role in restoring immune tolerance [26,27]